Conference Call with Fortis Healthcare Management and Analysts on Q1FY27 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company Fortis Healthcare announced Q1FY27 results Consolidated Financial Highlights: Revenue from Operations: The consolidated revenue for Q1FY27 stood at Rs 2,54,503 lakh, representing a YoY increase of 17.46% from Rs 2,16,672 lakh in Q1FY26 and a QoQ growth of 7.63% from Rs 2,36,467 lakh in Q4FY26. Total Income: Total income for Q1FY27 was Rs 2,55,950 lakh, up 17.29% YoY compared to Rs 2,18,212 lakh in Q1FY26 and an 8.04% increase QoQ from Rs 2,36,906 lakh in Q4FY26. Net Profit: The company reported a net profit of Rs 27,280 lakh in Q1FY27, reflecting a YoY growth of 2.26% from Rs 26,678 lakh in Q1FY26 and a marginal QoQ growth of 0.59% from Rs 27,119 lakh in Q4FY26. EBITDA: Consolidated EBITDA for Q1FY27 reached Rs 55,159 lakh, showing a YoY growth of 9.00% from Rs 50,607 lakh in Q1FY26 and a QoQ growth of 2.77% from Rs 53,672 lakh in Q4FY26. Earnings Per Share (EPS): Basic and diluted EPS for Q1FY27 was Rs 3.53, compared to Rs 3.45 in Q1FY26 and Rs 3.52 in Q4FY26. Standalone Financial Highlights: Revenue from Operations: Standalone revenue for Q1FY27 was Rs 48,945 lakh, a YoY increase of 13.03% from Rs 43,303 lakh in Q1FY26 and a QoQ increase of 6.23% from Rs 46,073 lakh in Q4FY26. Total Income: Standalone total income stood at Rs 50,837 lakh in Q1FY27, up 7.47% YoY from Rs 47,304 lakh in Q1FY26 and up 6.52% QoQ from Rs 47,726 lakh in Q4FY26. Net Profit from Continuing Operations: Standalone net profit reached Rs 4,778 lakh in Q1FY27, reflecting a YoY decline of 7.90% from Rs 5,188 lakh in Q1FY26 but a significant QoQ growth of 91.27% from Rs 2,498 lakh in Q4FY26. EBITDA: Standalone EBITDA for Q1FY27 was Rs 12,285 lakh, a YoY decrease of 4.11% from Rs 12,812 lakh in Q1FY26 and a QoQ decrease of 3.15% from Rs 12,684 lakh in Q4FY26. Business Highlights: Segment Performance (Healthcare): The healthcare segment reported a revenue of Rs 2,18,667 lakh in Q1FY27, growing 18.98% YoY from Rs 1,83,783 lakh and 8.08% QoQ from Rs 2,02,323 lakh. Segment results (EBIT) were Rs 34,701 lakh in Q1FY27 compared to Rs 33,327 lakh in Q1FY26. Segment Performance (Diagnostics): The diagnostics segment recorded a revenue of Rs 40,654 lakh in Q1FY27, representing a YoY growth of 10.23% from Rs 36,882 lakh and a QoQ increase of 4.98% from Rs 38,726 lakh. Segment results (EBIT) improved to Rs 6,823 lakh in Q1FY27 from Rs 5,593 lakh in Q1FY26. Brand Ownership Updates: On April 21, 2025, a "Certificate of Sale" was issued in favour of the company for the 'Fortis' brand and allied trademarks following a public auction bid of Rs 20,000 lakh. Similarly, Agilus Diagnostics Limited (formerly SRL Limited) acquired the 'SRL' brand and allied trademarks with a bid of Rs 8 crore, with the sale certificate issued on August 11, 2025. Strategic Acquisition: During the previous year, on January 09, 2026, the company consummated the acquisition of TMI Healthcare Private Limited, which runs the 'People Tree Hospital' in Bengaluru, for a cumulative transaction value of Rs 43,386 lakh. Dividend Recommendation: On May 22, 2026, the Board recommended a final dividend of Rs 1.00 per equity share (10% on face value of Rs 10 per share) for the financial year ended March 31, 2026. ESOP Grant: During the current quarter, the company approved the grant of 1,32,05,200 employee stock options (ESOPs) to eligible employees and has granted 1,30,87,600 ESOPs under the Fortis Healthcare Limited Employees Stock Option Scheme 2026. Labour Code Impact: For the year ended March 31, 2026, the company recognized a one-time estimated incremental impact of the new Labour Codes amounting to Rs 1,035 lakh (standalone) and Rs 5,518 lakh (consolidated) as an exceptional item. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare, said: “Building on the momentum of the previous year, we have made a positive start to the financial year, delivering a steady Q1 performance across both our hospital and diagnostics businesses. We recently entered into an O&M; agreement for a 300-bedded greenfield multi-specialty hospital to be developed in Cuttack. This marks Fortis Healthcare's entry into Odisha, further expanding our presence in growth markets. Our recent acquisitions in our focus geographies are ramping up well. We also continued to invest in our medical infrastructure by expanding our robotic systems across key facilities, reinforcing our commitment to clinical excellence and technology-led care.” “The diagnostics business also witnessed a steady revenue growth along with an improvement in EBITDA margins compared to the corresponding period of the previous year. We remain focused on delivering sustained growth across both our businesses over the remaining quarters of the financial year, supported by our expansion plans, strategic growth initiatives and a continued focus on operational excellence.” Result PDF